Taken together, this study provides a mechanism underlying the control of intracellular bacterial infection by ERRγ inverse agonist, GSK5182, although further studies would elucidate the role of Nramp1 in conjunction with FPN in intracellular bacterial infection. This evidence concerns the gene ESRRG and bacterial infectious disease.